Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronization process

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 24, Issue 1, 2007, Pages 1-40

  Trivedi, Namrata R ^a   Rajan, Maria Gerald ^a   Johnson, James R ^a   Shukla, Atul J ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Dosage forms; Extruder; Microcrystalline cellulose; Pellets; Process parameters; Spheronizer

Indexed keywords

AMYLOSE ETHOCEL; CALCIUM PHOSPHATE; CARBOMER; CARNUBA WAX; CELEX; CELLULOSE; CEOLUS; CHITOSAN; CROSCARMELLOSE SODIUM; CROSPOVIDONE; DEXTRIN; DICLOFENAC; EMOCEL; ETHYL CELLULOSE; EUDRAGIT; EXPLO TAB; GELUCIRE; GLYCEROL STEARATE; HYDROCHLOROTHIAZIDE; HYDROXYPROPYLMETHYLCELLULOSE; IBUPROFEN; INDOMETACIN; LACTOSE; MACROGOL; METHYLCELLULOSE; MICROCRYSTALLINE CELLULOSE; OPADRY; PARACETAMOL; PHARMACEL; POLYMER; POVIDONE; PROPRANOLOL; PROSOLV; STARCH; STARCH GLYCOLATE SODIUM; SUGAR; THEOPHYLLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIVAPUR; WAX; XANTHAN;

CAPSULE FILLING; COMPRESSION; CONTROLLED DRUG RELEASE; DRUG ABSORPTION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG RELEASE; DRUG SOLUBILITY; FLOW RATE; FREEZE DRYING; GASTROINTESTINAL TRACT; GRAVITY; PARTICLE SIZE; PELLET EXTRUSION; PHYSICAL CHEMISTRY; POROSITY; REVIEW; SCANNING ELECTRON MICROSCOPY; SOLUBILITY; SPHERONIZATION; SPRAY DRYING; SUSTAINED DRUG RELEASE; TABLET;

EID: 34247539538     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevTherDrugCarrierSyst.v24.i1.10     Document Type: Review

References (87)

1. Nakahara, inventor. Method and apparatus for making spherical granules. United States patent US 3277520. 1964.
2. Reynolds AD. A new technique for the production of spherical particles. Manuf Chem Aerosol News. 1970;41:40-3.
3. Conine JW Hadley HR. Preparation of small solid pharmaceutical spheres. Drug Cosmet Ind. 1970;106:38-41.
4. Ghebre-Sellassie I, Knoch A. Pelletization techniques. In: Swarbrick J, Boylan JC, editors. Encyclopedia of pharmaceutical technology. 2nd ed. Vol. 3. New York: Marcel Dekker; 2002. p. 2067-80.
5. Erkoboni DF. Extrusion/spheronization. In: Ghebre-Sellassie I, Martin C, editors. Pharmaceutical extrusion technology. Vol. 133. New York: Marcel Dekker; 2003. p. 277-322.
6. Bechgaard H, Nielsen GH. Controlled-release multiple-units and single-unit doses. A literature review. Drug Dev Ind Pharm. 1978;4(1):53-67.
7. Newton JM. Extrusion and extruders. In: Swarbrick J, Boylan JC, editors. Encyclopedia of pharmaceutical technology. 2nd ed. Vol. 3. New York: Marcel Dekker; 2002. p. 1220-36.
8. Harrison PJ, Newton JM, Rowe RC. Flow defects in wet powder mass extrusion. J Pharm Pharmacol. 1985;37(2):81-3.
9. Rowe R. Spheronization: a novel pill-making process. Pharm Int. 1985;6:119-23.
10. Baert L, Remon JP, Knight P, Newton JM. A comparison between the extrusion forces and sphere quality of a gravity feed extruder and a ram extruder. Int J Pharm. 1992;86(2-3):187-92.
11. Newton JM, Chapman SR, Rowe RC. The influence of process variables on the preparation and properties of spherical granules by the process of extrusion and spheronization. Int J Pharm. 1995;120(1):101-9.
12. Bashaiwoldu AB, Podczeck F, Newton JM. A study on the effect of drying techniques on the mechanical properties of pellets and compacted pellets. Eur J Pharm Sci. 2004;21(2-3):119-29.
13. Kleinebudde P. Shrinking and swelling properties of pellets containing microcrystalline cellulose and low substituted hydroxypropyl cellulose: I. Shrinking properties. Int J Pharm. 1994;109(3):209-19.
14. Eriksson M, Alderborn G, Nystrom C, Podczeck F, Newton JM. Comparison between and evaluation of some methods for the assessment of the sphericity of pellets. Int J Pharm. 1997;148(2):149-54.
15. Shah RD, Kabadi M, Pope DG, Augsburger LL. Physico-mechanical characterization of the extrusion-spheronization process. Part II: Rheological determinants for successful extrusion and spheronization. Pharm Res. 1995;12(4):496-507.
16. Fielden KE, Newton JM, O'Brien P, Rowe RC. Thermal studies on the interaction of water and microcrystalline cellulose. J Pharm Pharmacol. 1988;40(10):674-8.
17. Pinto JF, Wunde KF, Okoloekwe A. Evaluation of the potential use of poly(ethylene oxide) as tablet- and extrudate-forming material. AAPS PharmSci. 2004;6(2).
18. Sinha VR, Agrawal MK, Kumria R. Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization. Curr Drug Deliv. 2005;2(1):1-8.
19. Alvarez L, Concheiro A, Gomez-Amoza JL, Souto C, Martinez-Pacheco R. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization. Drug Dev Ind Pharm. 2002;28(4):451-6.
20. Heng PWS, Koo OMY. A study of the effects of the physical characteristics of microcrystalline cellulose on performance in extrusion spheronization. Pharm Res. 2001;18(4):480-7.
21. Fechner PM, Wartewig S, Fueting M, Heilmann A, Neubert RHH, Kleinebudde P. Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studied by Fourier transform Raman spectroscopy and environmental scanning electron microscopy. AAPS PharmSci. 2003;5(4).
22. Alvarez L, Concheiro A, Gomez-Amoza JL, Souto C, Martinez-Pacheco R. Powdered cellulose as excipient for extrusion-spheronization pellets of a cohesive hydrophobic drug. Eur J Pharm Biopharm. 2003;55(3):291-5.
23. Tomer G, Patel H, Podczeck F, Newton JM. Measuring the water retention capacities (MRC) of different microcrystalline cellulose grades. Eur J Pharm Sci. 2001;12(3):321-5.
24. Kleinebudde P, Schroder M, Schultz P, Muller BW, Waaler T, Nymo L. Importance of the fraction of microcrystalline cellulose and spheronization speed on the properties of extruded pellets made from binary mixtures. Pharm Dev Technol. 1999;4(3):397-404.
25. Nicklasson F, Alderborn G. Modulation of the tabletting behaviour of microcrystalline cellulose pellets by the incorporation of polyethylene glycol. Eur J Pharm Sci. 1999;9(1):57-65.
26. Jover I, Podczeck F, Newton M. Evaluation, by a statistically designed experiment, of an experimental grade of microcrystalline cellulose, Avicel 955, as a technology to aid the production of pellets with high drug loading. J Pharm Sci. 1996;85(7):700-5.
27. Johansson B, Alderborn G. Degree of pellet deformation during compaction and its relationship to the tensile strength of tablets formed of microcrystalline cellulose pellets. Int J Pharm. 1996;132(1):207-20.
28. Souto C, Rodriguez A, Parajes S, Martinez-Pacheco R. A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusion-spheronization. Eur J Pharm Biopharm. 2005;61(1-2):94-9.
29. Neau SH, Chow MY, Durrani MJ. Fabrication and characterization of extruded and spheronized beads containing Carbopol 974P, NF resin. Int J Pharm. 1996;131(1):47-55.
30. Gomez-Carracedo A, Alvarez-Lorenzo C, Gomez-Amoza JL, Martinez-Pacheco R, Souto C, Concheiro A. Extrusion-spheronization of blends of Carbopol 934 and microcrystalline cellulose. Drug Dev Ind Pharm. 2001;27(5):381-91.
31. Mezreb N, Charrueau C, Boy P, Allain P, Chaumeil JC. Production of Carbopol 974P and Carbopol 971P pellets by extrusion-spheronization: optimization of the processing parameters and water content. Drug Dev Ind Pharm. 2004;30(5):481-90.
32. Steckel H, Mindermann-Nogly F. Production of chitosan pellets by extrusion/spheronization. Eur J Pharm Biopharm. 2004;57(1):107-14.
33. Santos H, Veiga F, Pina M, Podczeck F, Sousa J. Physical properties of chitosan pellets produced by extrusion-spheronisation: influence of formulation variables. Int J Pharm. 2002;246(1-2):153-69.
34. Almeida Prieto S, Blanco Mendez J, Otero Espinar FJ. Starch-dextrin mixtures as base excipients for extrusion-spheronization pellets. Eur J Pharm Biopharm. 2005;59(3):511-21.
35. Chatchawalsaisin J, Podczeck F, Newton JM. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate. Eur J Pharm Sci. 2005;24(1):35-48.
36. Chatchawalsaisin J, Podczeck F, Newton JM. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation. Int J Pharm. 2004;275(1-2):41-60.
37. Santos H, Veiga F, Pina ME, Sousa JJ. Compaction, compression and drug release characteristics of xanthan gum pellets of different compositions. Eur J Pharm Sci. 2004;21(2-3):271-81.
38. Tho I, Sande SA, Kleinebudde P. Pectinic acid, a novel excipient for production of pellets by extrusion/spheronization: preliminary studies. Eur J Pharm Biopharm. 2002;54(1):95-9.
39. Tho T, Kleinebudde P, Sande SA. Extrusion/spheronization of pectin-based formulations. I. Screening of important factors. AAPS PharmSciTech [electronic resource]. 2001;2(4):26.
40. Tho T, Kleinebudde P, Sande SA. Extrusion/spheronization of pectin-based for-mulations. II. Effect of additive concentration in the granulation liquid. AAPS PharmSciTech [electronic resource]. 2001;2(4):27.
41. Junnila R, Palviainen P, Heinamaki J, Myllarinen P, Forssell P, Yliruusi J. Waxy corn starch: a potent cofiller in pellets produced by extrusion-spheronization. Pharm Dev Technol. 2000;5(1):67-76.
42. Chatlapalli R, Rohera BD. Physical characterization of HPMC and HEC and investigation of their use as pelletization aids. Int J Pharm. 1998;161(2):179-93.
43. Law MFL, Deasy PB. Use of hydrophilic polymers with microcrystalline cellulose to improve extrusion-spheronization. Eur J Pharm Biopharm. 1998;45(1):57-65.
44. Vervaet C, Remon JP. Bioavailability of hydrochlorothiazide from pellets, made by extrusion/spheronisation, containing polyethylene glycol 400 as a dissolution enhancer. Pharm Res. 1997;14(11):1644-6.
45. Wang C-C, Zhang G, Shah NH, Infeld MH, Malick AW, McGinity JW. Influence of plasticizers on the mechanical properties of pellets containing Eudragit RS 30D. Int J Pharm. 1997;152(2):153-63.
46. Agrawal AM, Howard MA, Neau SH. Extruded and spheronized beads containing no microcrystalline cellulose: Influence of formulation and process variables. Pharm Dev Technol. 2004;9(2):197-217.
47. Newton JM, Bontel S, Chatchawalsaisin J, Podczeck F. The preparation of spherical granules by extrusion/spheronization without microcrystalline cellulose. Pharm Technol Eur. 2004;16(10):21-2, 5-7.
48. Basit AW, Newton JM, Lacey LF. Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose. Pharm Dev Technol. 1999;4(4):499-505.
49. Bornhoft M, Thommes M, Kleinebudde P. Preliminary assessment of carrageenan as excipient for extrusion/spheronisation. Eur J Pharm Biopharm. 2005;59(1):127-31.
50. Chopra R, Newton JM, Alderborn G, Podczeck F. Preparation of pellets of different shape and their characterization. Pharm Dev Technol. 2001;6(4):495-503.
51. Sousa JJ, Sousa A, Podczeck F, Newton JM. Factors influencing the physical characteristics of pellets obtained by extrusion-spheronization. Int J Pharm. 2002;232(1-2):91-106.
52. Boutell S, Newton JM, Bloor JR, Hayes G. The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization. Int J Pharm. 2002;238(1-2):61-76.
53. Jerwanska E, Alderborn G, Newton JM, Nystroem C. The effect of water content on the porosity and liquid saturation of extruded cylinders. Int J Pharm. 1995;121(1):65-71.
54. Rodriguez EC, Torrado JJ, Nikolakakis I, Torrado S, Lastres JL, Malamataris S. Micromeritic and packing properties of diclofenac pellets and effects of some formulation variables. Drug Dev Ind Pharm. 2001;27(8):847-55.
55. Vervaet C, Remon JP. Influence of impeller design, method of screen perforation and perforation geometry on the quality of pellets made by extrusionspheronisation. Int J Pharm. 1996;133(1,2):29-37.
56. Sonaglio D, Bataille B, Jacob M. Effects of extrusion and formulation parameters on the production of paracetamol-microcrystalline cellulose extrudates. Pharmaceutica Acta Helvetiae. 1997;72(2):69-74.
57. Chopra R, Alderborn G, Podczeck F, Newton JM. The influence of pellet shape and surface properties on the drug release from uncoated and coated pellets. Int J Pharm. 2002;239(1-2):171-8.
58. Tomer G, Podczeck F, Newton JM. The influence of model drugs on the preparation of pellets by extrusion/spheronization: II spheronization parameters. Int J Pharm. 2002;231(1):107-19.
59. Tomer G, Podczeck F, Newton JM. The influence of type and quantity of model drug on the extrusion/spheronization of mixtures with microcrystalline cellulose. I. Extrusion parameters. Int J Pharm. 2001;217(1-2):237-48.
60. Mehta KA, Kislalioglu MS, Phuapradit W, Malick AW, Shah NH. Effect of formulation and process variables on porosity parameters and release rates from a multi-unit erosion matrix of a poorly soluble drug. J Controlled Release. 2000;63(1-2):201-11.
61. Sousa JJ, Sousa A, Podczeck F, Newton JM. Influence of process conditions on drug release from pellets. Int J Pharm. 1996;144(2):159-69.
62. Pinto JF, Buckton G, Newton JM. A relationship between surface free energy and polarity data and some physical properties of spheroids. Int J Pharm. 1995;118(1):95-101.
63. Sonaglio D, Bataille B, Ortigosa C, Jacob M. Factorial design in the feasibility of producing Microcel MC 101 pellets by extrusion/spheronization. Int J Pharm. 1995;115(1):53-60.
64. Elchidana PA, Deshpande SG. Microporous membrane drug delivery system for indomethacin. J Controlled Release. 1999;59(3):279-85.
65. Sriamornsak P, Puttipipatkhachorn S, Prakongpan S. Calcium pectinate gel coated pellets as an alternative carrier to calcium pectinate beads. Int J Pharm. 1997;156(2):189-94.
66. Basit AW, Podczeck F, Newton JM, Waddington WA, Ell PJ, Lacey LF. The use of formulation technology to assess regional gastrointestinal drug absorption in humans. Eur J Pharm Sci. 2004;21(2-3):179-89.
67. Sousa JJ, Sousa A, Moura MJ, Podczeck F, Newton JM. The influence of core materials and film coating on the drug release from coated pellets. Int J Pharm. 2002;233(1-2):111-22.
68. Bruce LD, Petereit H-U, Beckert T, McGinity JW. Properties of enteric coated sodium valproate pellets. Int J Pharm. 2003;264(1-2):85-96.
69. Debunne A, Vervaet C, Remon J-P. Development and in vitro evaluation of an enteric-coated multiparticulate drug delivery system for the administration of piroxicam to dogs. Eur J Pharm Biopharm. 2002;54(3):343-8.
70. Williams RO III, Liu J. Influence of processing and curing conditions on beads coated with an aqueous dispersion of cellulose acetate phthalate. Eur J Pharm Biopharm: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV. 2000;49(3):243-52.
71. Trenktrog T, Mueller BW, Specht FM, Seifert J. Enteric coated insulin pellets: development, drug release and in vivo evaluation. Eur J Pharm Sci. 1996;4(6):323-9.
72. Milojevic S, Newton JM, Cummings JH, Gibson GR, Botham RL, Ring SG, et al. Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using glucose pellets. J Controlled Release. 1996;38(1):85-94.
73. Saettone MF, Perini G, Rijli P, Rodriguez L, Cini M. Effect of different polymer-plasticizer combinations on 'in vitro' release of theophylline from coated pellets. Int J Pharm. 1995;126(1):83-8.
74. Kojima M, Nakagami H. Development of controlled release matrix pellets by annealing with micronized water-insoluble or enteric polymers. J Controlled Release. 2002;82(2-3):335-43.
75. Montousse C, Pruvost M, Rodriguez F, Brossard C. Extrusion-spheronization manufacture of Gelucire matrix beads. Drug Dev Ind Pharm. 1999;25(1):75-80.
76. Varshosaz J, Kennedy RA, Gipps EM. Use of enteric polymers for production of microspheres by extrusion-spheronization. Pharmaceutica Acta Helvetiae. 1997;72(3):145-52.
77. Sood A, Ashokraj Y, Panchagnula R. A multiunit matrix-based particulate system for controlled delivery of nifedipine. Pharm Technol. 2004;28(11):84-102.
78. Mehta KA, Kislalioglu MS, Phuapradit W, Malick AW, Shah NH. Release performance of a poorly soluble drug from a novel, Eudragit-based multi-unit erosion matrix. Int J Pharm. 2001;213(1-2):7-12.
79. Krogars K, Heinamaki J, Vesalahti J, Marvola M, Antikainen O, Yliruusi J. Extrusion-spheronization of pH-sensitive polymeric matrix pellets for possible colonic drug delivery. Int J Pharm. 2000;199(2):187-94.
80. Blanque D, Sternagel H, Podczeck F, Newton JM. Some factors influencing the formation and in vitro drug release from matrix pellets prepared by extrusion/spheronization. Int J Pharm. 1995;119(2):203-11.
81. Sood A, Ashokraj Y, Panchagnula R. Use of extrusion-spheronization to develop controlled-release dosage forms for diltiazem hydrochloride. Pharm Technol. 2004;28(4):62-85.
82. Gandhi R, Ashokraj Y, Kaul CL, Panchagnula R. Using extrusion- spheronization to develop controlled-release formulations of azithromycin. Pharm Technol. 2005;29(2):68-86.
83. Tunon A, Borjesson E, Frenning G, Alderborn G. Drug release from reservoir pellets compacted with some excipients of different physical properties. Eur J Pharm Sci. 2003;20(4-5):469-79.
84. Tunon A, Grasjo J, Alderborn G. Effect of intragranular porosity on compression behaviour of and drug release from reservoir pellets. Eur J Pharm Sci. 2003;19(5):333-44.
85. Tunon A, Alderborn G. Granule deformation and densification during compression of binary mixtures of granules. Int J Pharm. 2001;222(1):65-76.
86. Habib YS, Augsburger LL, Shangraw RF. Production of inert cushioning beads: effect of excipients on the physicomechanical properties of freeze-dried beads containing microcrystalline cellulose produced by extrusion- spheronization. Int J Pharm. 2002;233(1-2):67-83.
87. Iyer RM, Sandhu HK, Shah NH, Phuapradit W, Ahmed HM. Scale-up of extrusion and spheronization. Drugs Pharm Sci. 2006;157:325-69.